{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:29:21Z","timestamp":1793755761007,"version":"4.6.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jtct.2025.09.008","type":"journal-article","created":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T16:55:14Z","timestamp":1757350514000},"page":"1041.e1-1041.e12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Optimizing MMF Dosing for GVHD Prophylaxis in Umbilical Cord Blood Transplantation: A Retrospective Study in Non-Remission Myeloid Malignancies"],"prefix":"10.1016","volume":"31","author":[{"given":"Jotaro","family":"Yamamoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisashi","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika","family":"Kuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otoya","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8238-8672","authenticated-orcid":false,"given":"Kyosuke","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosei","family":"Kageyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9256-609X","authenticated-orcid":false,"given":"Daisuke","family":"Kaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Taya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsuke","family":"Takagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Go","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Asano-Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Wake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuichi","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5952-5926","authenticated-orcid":false,"given":"Naoyuki","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jtct.2025.09.008_bib0001","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1182\/blood-2013-02-453175","article-title":"Umbilical cord blood transplantation: the first 25 years and beyond","volume":"122","author":"Ballen","year":"2013","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jtct.2025.09.008_bib0002","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41409-019-0546-9","article-title":"Cord blood research, banking, and transplantation: achievements, challenges, and perspectives","volume":"55","author":"Mayani","year":"2020","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.jtct.2025.09.008_bib0003","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1038\/s41375-021-01474-0","article-title":"Comparing cord blood transplantation and matched related donor transplantation in non-remission acute myeloid leukemia","volume":"36","author":"Shimomura","year":"2022","journal-title":"Leukemia"},{"issue":"10","key":"10.1016\/j.jtct.2025.09.008_bib0004","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1056\/NEJMoa1602074","article-title":"Cord-blood transplantation in patients with minimal residual disease","volume":"375","author":"Milano","year":"2016","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.jtct.2025.09.008_bib0005","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jtct.2023.03.001","article-title":"Effect of graft-versus-host disease on post-transplantation outcomes following single cord blood transplantation compared with haploidentical transplantation with post-transplantation cyclophosphamide for adult acute myeloid leukemia","volume":"29","author":"Konuma","year":"2023","journal-title":"Transplant Cell Ther"},{"issue":"4","key":"10.1016\/j.jtct.2025.09.008_bib0006","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/ajh.25705","article-title":"Improvement of early mortality in single-unit cord blood transplantation for Japanese adults from 1998 to 2017","volume":"95","author":"Konuma","year":"2020","journal-title":"Am J Hematol"},{"issue":"9","key":"10.1016\/j.jtct.2025.09.008_bib0007","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1182\/blood-2011-11-354563","article-title":"Selection of optimal alternative graft source: mismatched unrelated donor, umbilical cord blood, or haploidentical transplant","volume":"119","author":"Ballen","year":"2012","journal-title":"Blood"},{"issue":"22","key":"10.1016\/j.jtct.2025.09.008_bib0008","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1056\/NEJMoa041276","article-title":"Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia","volume":"351","author":"Laughlin","year":"2004","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.jtct.2025.09.008_bib0009","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/TP.0b013e318223d7ac","article-title":"Mycophenolate and tacrolimus for graft-versus-host disease prophylaxis for elderly after cord blood transplantation: a matched pair comparison with tacrolimus alone","volume":"92","author":"Uchida","year":"2011","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.jtct.2025.09.008_bib0010","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/bmt.2016.255","article-title":"Exploratory research for optimal GvHD prophylaxis after single unit CBT in adults: short-term methotrexate reduced the incidence of severe GvHD more than mycophenolate mofetil","volume":"52","author":"Terakura","year":"2017","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"10.1016\/j.jtct.2025.09.008_bib0011","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.bbmt.2015.01.023","article-title":"Higher dose of mycophenolate mofetil reduces acute graft-versus-host disease in reduced intensity conditioning double umbilical cord blood transplantation","volume":"21","author":"Bejanyan","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"10.1016\/j.jtct.2025.09.008_bib0012","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.bbmt.2015.01.024","article-title":"Intensified mycophenolate mofetil dosing and higher mycophenolic acid trough levels reduce severe acute graft-versus-host disease after double-unit cord blood transplantation","volume":"21","author":"Harnicar","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"10.1016\/j.jtct.2025.09.008_bib0013","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/ejh.13537","article-title":"Weight-based mycophenolate mofetil dosing predicts acute GVHD and relapse after allogeneic hematopoietic cell transplantation","volume":"106","author":"Bejanyan","year":"2021","journal-title":"Eur J Haematol"},{"issue":"8","key":"10.1016\/j.jtct.2025.09.008_bib0014","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.bbmt.2013.04.026","article-title":"Nonrelapse mortality and mycophenolic acid exposure in nonmyeloablative hematopoietic cell transplantation","volume":"19","author":"McDermott","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"issue":"10","key":"10.1016\/j.jtct.2025.09.008_bib0015","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/j.bbmt.2014.06.024","article-title":"Anti-HLA antibodies other than against HLA-A, -B, -DRB1 adversely affect engraftment and nonrelapse mortality in HLA-mismatched single cord blood transplantation: possible implications of unrecognized donor-specific antibodies","volume":"20","author":"Yamamoto","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"10.1016\/j.jtct.2025.09.008_bib0016","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.jtct.2024.04.011","article-title":"Lymphocyte crossmatch testing or donor HLA-DP and -DQ allele typing effectiveness in single cord blood transplantation for patients with Anti-HLA antibodies other than against HLA-A, -B, -C, and -DRB1","volume":"30","author":"Osada","year":"2024","journal-title":"Transplant Cell Ther"},{"issue":"3","key":"10.1016\/j.jtct.2025.09.008_bib0017","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.bbmt.2008.12.497","article-title":"Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research","volume":"15","author":"Giralt","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"10.1016\/j.jtct.2025.09.008_bib0018","first-page":"825","article-title":"1994 consensus conference on acute GVHD grading","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.jtct.2025.09.008_bib0019","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 diagnosis and staging working group report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"23","key":"10.1016\/j.jtct.2025.09.008_bib0020","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1182\/blood-2014-01-552984","article-title":"Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation","volume":"123","author":"Armand","year":"2014","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jtct.2025.09.008_bib0021","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.jtct.2025.09.008_bib0022","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/jcph.14","article-title":"Population pharmacokinetics and dose optimization of mycophenolic acid in HCT recipients receiving oral mycophenolate mofetil","volume":"53","author":"Li","year":"2013","journal-title":"J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.jtct.2025.09.008_bib0023","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/FTD.0000000000000947","article-title":"Drug-drug interactions between mycophenolic acid and proton pump inhibitors: a systematic review and meta-analysis","volume":"44","author":"Sakuludomkan","year":"2022","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.jtct.2025.09.008_bib0024","doi-asserted-by":"crossref","first-page":"66","DOI":"10.12659\/AOT.906164","article-title":"Pharmacokinetic drug-drug interactions between immunosuppressant and anti-infective agents: antimetabolites and corticosteroids","volume":"23","author":"Van Matre","year":"2008","journal-title":"Ann Transplant"},{"issue":"12","key":"10.1016\/j.jtct.2025.09.008_bib0025","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1111\/bcp.14354","article-title":"Drug monitoring for mycophenolic acid in graft-vs-host disease prophylaxis in cord blood transplantation","volume":"86","author":"Muranushi","year":"2020","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.jtct.2025.09.008_bib0026","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/bmt.2010.59","article-title":"Delayed neutrophil engraftment in cord blood transplantation with intensive administration of mycophenolate mofetil for GVHD prophylaxis","volume":"46","author":"Okamura","year":"2011","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.jtct.2025.09.008_bib0027","doi-asserted-by":"crossref","first-page":"406","DOI":"10.3390\/jcm10030406","article-title":"Area-under-the-Curve-Based Mycophenolate Mofetil Dosage May Contribute to Decrease the Incidence of Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation in Pediatric Patients","volume":"10","author":"Carlone","year":"2021","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.jtct.2025.09.008_bib0028","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/ki.2010.84","article-title":"Mycophenolic acid suppresses granulopoiesis by inhibition of interleukin-17 production","volume":"78","author":"Von Vietinghoff","year":"2010","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.jtct.2025.09.008_bib0029","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.bbmt.2020.10.008","article-title":"Prophylactic foscarnet for human herpesvirus 6: effect on hematopoietic engraftment after reduced-intensity conditioning umbilical cord blood transplantation","volume":"27","author":"Jurdi","year":"2021","journal-title":"Transplant Cell Ther"},{"issue":"4","key":"10.1016\/j.jtct.2025.09.008_bib0030","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1399-3062.2009.00407.x","article-title":"Mycophenolate mofetil: effects on cellular immune subsets, infectious complications, and antimicrobial activity","volume":"11","author":"Ritter","year":"2009","journal-title":"Transplant Infect Dis"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636725014101?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636725014101?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T13:18:07Z","timestamp":1764940687000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636725014101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S2666636725014101"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2025.09.008","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimizing MMF Dosing for GVHD Prophylaxis in Umbilical Cord Blood Transplantation: A Retrospective Study in Non-Remission Myeloid Malignancies","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2025.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}